🇺🇸 FDA
Patent

US 12295971

Compositions and methods for enhancing adoptive T cell therapeutics

granted A61KA61K2239/13A61K35/17

Quick answer

US patent 12295971 (Compositions and methods for enhancing adoptive T cell therapeutics) held by The Regents of the University of California expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2239/13, A61K35/17, A61K40/11, A61K40/31